CVE-2021-20686
Cross-site scripting vulnerability in Kagemai 0.8.8 allows remote attackers to inject an...
Cross-site scripting vulnerability in Kagemai 0.8.8 allows remote attackers to inject an arbitrary script via unspecified vectors.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- None
- User interaction
- Required
What an attacker can affect
- Confidentiality
- Low
- Integrity
- Low
- Availability
- None
Exploit likelihood
What each source reports
NVD Score used
Cross-site scripting vulnerability in Kagemai 0.8.8 allows remote attackers to inject an arbitrary script via unspecified vectors.
- Record
CVE-2021-20686- CVSS 3.1
- 6.1 Medium
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N - CVSS 2.0
- 4.3 Medium
AV:N/AC:M/Au:N/C:N/I:P/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
CVE List No score
Cross-site scripting vulnerability in Kagemai 0.8.8 allows remote attackers to inject an arbitrary script via unspecified vectors.
- Record
CVE-2021-20686- Updated
- 2026-11-02
EUVDEUVD-2021-8101 No score
Cross-site scripting vulnerability in Kagemai 0.8.8 allows remote attackers to inject an arbitrary script via unspecified vectors.
- Record
EUVD-2021-8101- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-p4f7-mw34-f75x
Cross-site scripting vulnerability in Kagemai 0.8.8 allows remote attackers to inject an...
Cross-site scripting vulnerability in Kagemai 0.8.8 allows remote attackers to inject an arbitrary script via unspecified vectors.
- Record
GHSA-p4f7-mw34-f75x- CVSS 3.1
- 6.1 Medium
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2021-20686 is a medium vulnerability (CVSS 6.1) in Daifukuya Kagemai, published April 7, 2021. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.78%, the 56th percentile. No source names a fixed version.